Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 79
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Claxton, Karl Palmer, Stephen Longworth, Louise Bojke, Laura Griffin, Susan Soares, Marta Spackman, Eldon and Rothery, Claire 2016. A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage Decisions. Value in Health,

    Vallejo-Torres, Laura García-Lorenzo, Borja Castilla, Iván Valcárcel-Nazco, Cristina García-Pérez, Lidia Linertová, Renata Polentinos-Castro, Elena and Serrano-Aguilar, Pedro 2016. On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?. Value in Health,

    Buchanan, James and Wordsworth, Sarah 2015. Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?. PharmacoEconomics, Vol. 33, Issue. 6, p. 571.

    Kulvik, Martti Hermans, Raine Linnosmaa, Ismo and Shalowitz, Joel 2015. An economic model to assess the cost-benefit of BNCT. Applied Radiation and Isotopes, Vol. 106, p. 3.

    Ryen, Linda and Svensson, Mikael 2015. The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature. Health Economics, Vol. 24, Issue. 10, p. 1289.

    Zhang, Hui Wernz, Christian and Slonim, Anthony D. 2015. Aligning incentives in health care: a multiscale decision theory approach. EURO Journal on Decision Processes,

    Conrad, Douglas A. and Sullivan, Sean D. 2014. Wiley StatsRef: Statistics Reference Online.

    Gutjahr, G. and Brannath, W. 2013. Multiple tests of cost-effectiveness angles. Statistics in Medicine, Vol. 32, Issue. 10, p. 1754.

    Pitman, R.J. Nagy, L.D. and Sculpher, M.J. 2013. Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model. Vaccine, Vol. 31, Issue. 6, p. 927.

    Robinson, Angela Gyrd-Hansen, Dorte Bacon, Philomena Baker, Rachel Pennington, Mark and Donaldson, Cam 2013. Estimating a WTP-based value of a QALY: The ‘chained’ approach. Social Science & Medicine, Vol. 92, p. 92.

    Ryan, Padhraig Revill, Paul Devane, Declan and Normand, Charles 2013. An assessment of the cost-effectiveness of midwife-led care in the United Kingdom. Midwifery, Vol. 29, Issue. 4, p. 368.

    Baker, Rachel Chilton, Sue Donaldson, Cam Jones-Lee, Michael Lancsar, Emily Mason, Helen Metcalf, Hugh Pennington, Mark and Wildman, John 2011. Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE. Health Economics, Policy and Law, Vol. 6, Issue. 04, p. 435.

    Claxton, Karl Paulden, Mike Gravelle, Hugh Brouwer, Werner and Culyer, Anthony J. 2011. Discounting and decision making in the economic evaluation of health-care technologies. Health Economics, Vol. 20, Issue. 1, p. 2.

    Donaldson, Cam Baker, Rachel Mason, Helen Jones-Lee, Michael Lancsar, Emily Wildman, John Bateman, Ian Loomes, Graham Robinson, Angela Sugden, Robert Prades, Jose Luis Pinto Ryan, Mandy Shackley, Phil and Smith, Richard 2011. The social value of a QALY: raising the bar or barring the raise?. BMC Health Services Research, Vol. 11, Issue. 1,

    Garber, Alan M. and Sculpher, Mark J. 2011.

    Griffin, Susan C. Claxton, Karl P. Palmer, Stephen J. and Sculpher, Mark J. 2011. Dangerous omissions: the consequences of ignoring decision uncertainty. Health Economics, Vol. 20, Issue. 2, p. 212.

    Meltzer, David O. and Smith, Peter C. 2011.

    Willan, Andrew R. 2011. Sample Size Determination for Cost-Effectiveness Trials. PharmacoEconomics, Vol. 29, Issue. 11, p. 933.

    Liljas, Bengt 2010. On the welfare theoretic foundation of cost-effectiveness analysis—the case when survival is not affected. The European Journal of Health Economics, Vol. 11, Issue. 1, p. 5.

    Smith, Richard D. and Sach, Tracey H. 2010. Contingent valuation: what needs to be done?. Health Economics, Policy and Law, Vol. 5, Issue. 01, p. 91.

  • International Journal of Technology Assessment in Health Care, Volume 7, Issue 1
  • January 1991, pp. 12-21

On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses

  • Charles E. Phelps (a1) and Alvin I. Mushlin (a1)
  • DOI:
  • Published online: 01 March 2009

Many people believe that cost-effectiveness (CE) and cost-benefit (CB) analyses require different assumptions. However, when CE analysis supports decisions to use medical resources, it makes the same assumptions that CB analysis requires. They are mathematically equivalent. Differences between CE and CB hinge more on reporting style than on fundamental assumptions.

Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.D. M. Eddy , V. Hasselblad , W. McGivney , & W. Hendee The value of mammography screening in women under age 50 years. Journal of the American Medical Association, 1988, 259, 1512

4.D. Neuhauser , & A. M. Lewicki What can we learn from the 6th stool guaiac? New England Journal of Medicine, 1975, 293, 226–28.

6.G. W. Torrance Measurement of health status utilities for economic appraisal: A review. Journal of Health Economics, 1986, 5, 130.

9.M. C. Weinstein , & W. B. Stason Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 716–21.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *